Despite the huge societal costs of AMR, there is no viable market for new antibiotics. Let’s create an environment where we champion innovation and antibiotic R&D. Learn more: https://t.co/FGpV6Mc15r
#WeWontRest#EAAD
Antimicrobial resistance threatens modern medicine as we know it. Unless we find a solution together. Find out more: https://t.co/FGpV6Mc15r #WeWontRest#EAAD
The creation of #HERA is a first step to putting Europe on the front foot in addressing global health threats. Read our recommendations on how it should work: https://t.co/GXPLUYtNfw
#HealthUnion@VaccinesEurope
Interested in EU health policy? EFPIA is looking for an intern to join the public affairs team in January 2022. Check our website for more information ➡️ https://t.co/hFedyOaHtp
#COVID19 highlighted some of our strengths while revealing a range of weaknesses. Our task now is to build on what worked and address systemic shortcomings: we must keep the best and fix the rest. Read this op-ed by @NathalieMoll👇https://t.co/JRQ7avzD8O
#WeWontRest#HealthUnion
Join the @EFPIA Public Affairs Team! Want to learn more about what we do? Visit https://t.co/1d4pXsYwsk and join us in our effort to make more health! Don't hesitate to reach out to me bilaterally in case of questions
EFPIA welcomes the proposals from the @EU_Commission to strengthen the resilience and preparedness of Europe against serious cross-border health threats: https://t.co/dIG85qHe6b @Efpia
On #EAAD, @NathalieMoll reminds us that "In Europe we have a robust research ecosystem, but if we look at some areas such as #AMR, more can be done. We are lacking the right incentives to make sure we can bring new antibiotics to the market" #POLITICOHealthCare Summit #WeWontRest
#AMR is a global issue that requires coordinated action. By 2050, 10 million people could lose their lives to drug-resistant infections each year, if current infection and resistance trends are not reversed #EAAD#KeepAntibioticsWorking#WeWontRest https://t.co/ctWQ8nZHiw
"That the EU is currently overdependent on medicines and active pharmaceutical ingredients from non-EU sources is a myth based on generalisation," says Simon White, Chair of @EFPIA Supply Chain WG in his response to @Europarl_EN resolution on shortages https://t.co/4ycb9vYx3N
The report by @CristianSBusoi on EU4Health approved by @EP_Environment with 74 votes to 5.
9.4 billion EUR budget needed to fill gaps exposed by COVID-19 and ensure health systems can face future threats to public health.
Read more in the press release
https://t.co/uyd4V7vv9a
How can we prevent drug shortages? Join the conversation on 22 October to find out everything you always wanted to know about drug shortages (but were afraid to ask) ✏️Register here ▶️ https://t.co/FuTrg0ZjSq
#QuestionsInspireSolutions#WeWontRest
“We need to be better at incentivising areas such as #AMR, also as called upon by the #EP. We see the emphasis given in the mission letters of President @vonderleyen and we want to participate and collaborate.” @NathalieMoll@EFPIA
.@AMRAlliance members adopted a common framework for responsible manufacturing of #antibiotics.
More on practices that minimize the release of antibiotics into the environment from drug production and formulation to effective waste management & control: https://t.co/yvP1d8AmF4